Generic vs. Brand Name Drugs: Unveiling the Differences, Myths, and Realities
In the realm of pharmaceuticals, the choice between generic and brand-name drugs is a critical decision, both for healthcare professionals and consumers. This article... Read more.
Generic Drugmaker Stada has Spun off Russian Business
In recent news, the generic drugmaker Stada has reportedly separated its Russian business, establishing a distinct entity named Nizhpharm, as per information from... Read more.
Use of Unapproved Fat-Dissolving Injections Poses Serious Health Risks FDA Warns
In a recent announcement, the Food and Drug Administration (FDA) has issued a stern warning about the potential dangers associated with the use of unapproved fat-dissolving... Read more.
FDA Approves Safety Labeling Changes for Opioid Pain Medicines
The Food and Drug Administration (FDA) has officially granted final approval and implemented mandatory safety labeling updates for opioid analgesic products, marking... Read more.
Jazz Pharmaceuticals Faces Setback as PTSD Drug Fails Mid-Stage Trial
Jazz Pharmaceuticals (JAZZ.O) encountered a setback as its investigational drug, JZP150, designed for the treatment of post-traumatic stress disorder (PTSD), failed... Read more.
FDA Issues Warning: Counterfeit Ozempic Found in U.S. Drug Supply Chain
The U.S. Food and Drug Administration (FDA) has issued a stark warning to consumers, cautioning against the use of counterfeit versions of Novo Nordisk’s diabetes... Read more.
Bristol Myers Acquire Karuna Therapeutics in $14 Billion Megadeal
In a strategic move, Bristol Myers Squibb has announced a groundbreaking acquisition of Karuna Therapeutics for a staggering $14 billion, marking a significant leap... Read more.
India’s High-Stakes Probe into Alleged Bribery Scandal in Toxic Syrup Tests Reaches Climax
In a significant development, India is reaching the final stages of its investigation into allegations that a state drug regulator accepted a bribe to manipulate... Read more.
Ono Pharmaceutical Collaborates with EVQLV for AI-Powered Antibody Development
Ono Pharmaceutical Co., Ltd., a prominent Japanese pharmaceutical company, has announced a strategic collaboration with EVQLV, INC, based in Miami, Florida, to leverage... Read more.
Ionis Pharmaceuticals’ WAINUA™ (Eplontersen) Secures FDA Approval for Hereditary Transthyretin-Mediated Amyloidosis Treatment
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) has achieved a groundbreaking milestone with the U.S. Food and Drug Administration (FDA) granting approval for WAINUA™... Read more.